Fipravirimat

DB21578InvestigationalSmall molecule

Fipravirimat is a small molecule drug. The usage of the INN stem '-virimat' in the name indicates that Fipravirimat is a antiviral, disruptor of viral maturation. Fipravirimat is under investigation... Fipravirimat is under investigation in clinical trial NCT04493216 (A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults).

Mechanism: Pharmacologically active on Gag polyprotein
Curator reviewed
Formula / weight: C₄₃H₆₇FN₂O₄S · 727.08 g/mol (avg)
Code names: GSK-3640254 · GSK-3640254A

Resolves to

Compound

UNIIM5FP5REG5QCAS1818867-24-1ChEMBLCHEMBL5201510ChEBI759070PubChem118435805

Structure

InChIKeyYFSNREBZTKMFEB-DHGHKPCRSA-NSMILES

[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC=C(C4=CC[C@](CF)(CC4)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)NCCN1CCS(=O)(=O)CC1)C(C)=C

Targets

O93182gag

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fipravirimat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account